Article
Identification and genetic validation of potential therapeutic targets for pulmonary hypertension through multi-omics causal inference.
Medicine - 6 Feb 2026
Wu Chaoling, Zhao Wenbo, Zhu Xiaojing, Li Yuanbin, Chen Zhihong, Yan Xu
Abstract excerpt
Pulmonary hypertension (PH) underscores the urgent need for novel therapeutic targets. This study aimed to employ a proteome-wide Mendelian randomization (MR) approach to systematically identify circulating proteins causally associated with PH, thereby providing genetically validated candidate targets for drug development. We adopted a 2-sample MR design, integrating large-scale plasma proteomic quantitative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
